Search
Search
About
Log in
Join
Experiences with
Interferon beta-1b
Posts
Communities
1,080 public posts
Filter results
ABBVIE ANNOUNCES NEW PHASE 3B RESULTS IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b (GT1b) chronic hepatitis C virus (HCV) infected adult patients with compensated liver
kcohen
in
HFI Connect - Hepatitis
9 years ago
U.S. Eyes Cuba's Lung Cancer Vaccine and Hepatitis Research
For several years, Cuba has had a promising vaccine against lung cancer, and the United States wants it. However, that’s not the only biotech invention that the Caribbean nation has up its sleeve—for several years, U.S. health experts have also been eyeing the island’s hepatitis research, Wired reports
For several years, Cuba has had a promising vaccine against lung cancer, and the United States wants it. However, that’s not the only biotech invention that the Caribbean nation has up its sleeve—for several years, U.S. health experts have also been eyeing the island’s hepatitis research, Wired reports
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Hepatitis C - The Long Goodbye
The long goodbye is often used to describe the drawn out fading of a person’s mind, who is suffering from Alzheimer’s disease. But for my Mom, it was because of Hepatitis C. My Mom worked as a hospital lab technician for most of her career. She remembered accidentally sticking her hand, with the contaminated
The long goodbye is often used to describe the drawn out fading of a person’s mind, who is suffering from Alzheimer’s disease. But for my Mom, it was because of Hepatitis C. My Mom worked as a hospital lab technician for most of her career. She remembered accidentally sticking her hand, with the contaminated
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Coffee and the Liver
First let’s talk about the good news—the possible health benefits: Liver Fibrosis / HCV Disease Progression: In a review of 177 patients—121 patients with HCV who drank about 2 ¼ cups of coffee a day were found to have reduced levels of liver fibrosis. The results were only found in those who drank
First let’s talk about the good news—the possible health benefits: Liver Fibrosis / HCV Disease Progression: In a review of 177 patients—121 patients with HCV who drank about 2 ¼ cups of coffee a day were found to have reduced levels of liver fibrosis. The results were only found in those who drank
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
World Health Organization Throws Weight Behind Hep C Treatments
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
The World Health Organization (WHO) has added the new hepatitis C virus (HCV) medications to its Model List of Essential Medicines. The move represents WHO’s commitment to encouraging access to hep C drugs worldwide. Governments and institutions often consult the WHO reference for guidance on their own
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%.
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%.
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee
Any comments? [i]Clin Endocrinol (Oxf). 2015 May 23. doi: 10.1111/cen.12824. [Epub ahead of print]
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee.
Okosieme O1, Gilbert J2, Abraham P3, Boelaert K4, Dayan C5, Gurnell M6, Leese G7, McCabe
Any comments? [i]Clin Endocrinol (Oxf). 2015 May 23. doi: 10.1111/cen.12824. [Epub ahead of print]
Management of Primary Hypothyroidism Statement by the British Thyroid Association Executive Committee.
Okosieme O1, Gilbert J2, Abraham P3, Boelaert K4, Dayan C5, Gurnell M6, Leese G7, McCabe
helvella
Thyroid UK
in
Thyroid UK
9 years ago
Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis
The dossier assessment is a procedural part of the Reform of the Market for Medicinal Products Act, overseen by the Federal Joint Committee (G-BA). The G-BA conducts a commenting procedure once the dossier assessment is complete and then determines the extent of the added benefit determined by the Institute
The dossier assessment is a procedural part of the Reform of the Market for Medicinal Products Act, overseen by the Federal Joint Committee (G-BA). The G-BA conducts a commenting procedure once the dossier assessment is complete and then determines the extent of the added benefit determined by the Institute
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Preparing for Hepatitis C Treatment: Part 1by Alan Franciscus
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
This first of a two-part series, originally appeared in the HCV Advocate; it presents an overview of how to prepare for hepatitis C treatment. Alan FranciscusTreatment of hepatitis C has made great advances from the early days. Back when interferon was first approved, the cure rates were about 10%
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Sovaldi, Interferon and Ribavirin Cures Almost All Hep C Genotype 3
http://www.hepmag.com/articles/BOSON_genotype_3_2501_27135.shtml
http://www.hepmag.com/articles/BOSON_genotype_3_2501_27135.shtml
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Merck’s Hep C Meds Work Well in Treatment-Experienced People
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
Twelve weeks of Merck’s grazoprevir and elbasvir, plus ribavirin, cured nearly all treatment-experienced people with genotype 1 of hepatitis C virus (HCV) in a small trial, including those with cirrhosis. The Phase II C-SALVAGE trial included 79 people who had failed a previous regimen of interferon,
kuzoigwe
in
HFI Connect - Hepatitis
9 years ago
Auto Immune
Hi All, I have been suffering from uveitis caused by an auto immune response for the last seven years. None of my doctors are wanting to put a label on it, but I have had many other problems - such as livedo reticularis amongst other things. The steriods have stopped controlling the situation, as
Hi All, I have been suffering from uveitis caused by an auto immune response for the last seven years. None of my doctors are wanting to put a label on it, but I have had many other problems - such as livedo reticularis amongst other things. The steriods have stopped controlling the situation, as
tatbagend
in
LUPUS UK
9 years ago
The future for CLL?
In the last few years, we've seen some great advances in the efficacy of new treatments for CLL, with very encouraging progress towards a cure. There has even been talk that we may have achieved the breakthrough that Imatinib (perhaps better know as Gleevec) was for a sister leukaemia to CLL - CML or
In the last few years, we've seen some great advances in the efficacy of new treatments for CLL, with very encouraging progress towards a cure. There has even been talk that we may have achieved the breakthrough that Imatinib (perhaps better know as Gleevec) was for a sister leukaemia to CLL - CML or
AussieNeil
Partner
in
CLL Support
9 years ago
Iodine Excess as an Environmental Risk Factor for Autoimmune Thyroid Disease
I have long been extremely cautious about the use of iodine in relation to thyroid disorders. Yet many people point out the high intake of iodine in Japan and suggest doses of as high as 50 milligrams a day. So it is particularly interesting that this paper originates in Japan and cautions about iodine
I have long been extremely cautious about the use of iodine in relation to thyroid disorders. Yet many people point out the high intake of iodine in Japan and suggest doses of as high as 50 milligrams a day. So it is particularly interesting that this paper originates in Japan and cautions about iodine
helvella
Thyroid UK
in
Thyroid UK
9 years ago
sovaldi and Harvoni..who gets treatment?
I was so happy to hear that at last Nice has given the go ahead to treat people with sovaldi and Harvoni....for the vast majority of people this is what they have been waiting for..but it is not as clear cut as i thought...it looks as if people that have been treated before and not cleared the hep c
I was so happy to hear that at last Nice has given the go ahead to treat people with sovaldi and Harvoni....for the vast majority of people this is what they have been waiting for..but it is not as clear cut as i thought...it looks as if people that have been treated before and not cleared the hep c
ballie52
in
British Liver Trust
9 years ago
Ruxolitinib for PV
Are there many people on here who are taking Ruxo for PV in UK, how are you doing on it, are you having any side effects, how long have you been on it and what dose are you on. Was it hard to get it in UK as I understand it is not yet approved, did you have to "fail" on Hydra and Interferon. I am looking
Are there many people on here who are taking Ruxo for PV in UK, how are you doing on it, are you having any side effects, how long have you been on it and what dose are you on. Was it hard to get it in UK as I understand it is not yet approved, did you have to "fail" on Hydra and Interferon. I am looking
ainslie
in
MPN Voice
9 years ago
Feeling scared
Sat in bed last night feeling my anxiety levels creeping up and was lucky enough to notice the link at the bottom of the MPD homepage. Spent time reading and felt something just less than the normal state of panic I have been in recently. Diagnosed Sept 2013 at 42 years old, started on aspirin but
Sat in bed last night feeling my anxiety levels creeping up and was lucky enough to notice the link at the bottom of the MPD homepage. Spent time reading and felt something just less than the normal state of panic I have been in recently. Diagnosed Sept 2013 at 42 years old, started on aspirin but
Grace71
in
MPN Voice
9 years ago
Does Pegylated interferon alfa-2a cure ET? Some paper show yes. Is this credible?
I found a paper Quintás-Cardama A, Kantarjian H, Manshouri T, et al. Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera[J]. Journal of Clinical Oncology, 2009, 27(32): 5418-5424. This show the
I found a paper Quintás-Cardama A, Kantarjian H, Manshouri T, et al. Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera[J]. Journal of Clinical Oncology, 2009, 27(32): 5418-5424. This show the
Midas_
in
MPN Voice
9 years ago
1
...
49
50
51
...
54
Next page
10
20
30
40
50
Filter results
Clear filters
Posted in
All communities
MPN Voice
772 results
My MSAA Community
39 results
British Liver Trust
28 results
View top 10 communities
Sort by
Most Relevant
Newest